RELKYZO owner Contact Information online
from ACORDA THERAPEUTICS, INC.
RELKYZO
US serial number:87212071
Application filling date:Oct. 21, 2016
Register:Principal
Mark type:Trademark
Status:Application has been published for opposition. The opposition period begins on the date of publication.
Status date:Apr. 18, 2017
Publication date:Apr. 18, 2017
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:pharmaceutical and biological preparations used in the treatment of diseases
disorders or conditions of the nervous system
Current owner owner name:ACORDA THERAPEUTICS, INC.
Current owner owner address:420 Saw Mill River Road
Ardsley,
NEW YORK
UNITED STATES
10502
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Joseph C. Guagliardo
Attorney email:guagliaj@pepperlaw.com
Attorney docket number:127304.19130
Attorney email authorized:Yes
Correspondent name address:JOSEPH C. GUAGLIARDO
PEPPER HAMILTON LLP
EIGHTEENTH AND ARCH STREETS
3000 TWO LOGAN SQUARE
PHILADELPHIA,
PENNSYLVANIA
UNITED STATES
19103
Correspondent phone:215.981.4865
Correspondent email:guagliaj@pepperlaw.com
maddoxd@pepperlaw.com
catalant@pepperlaw.com
Correspondent fax:800.459.5024
Correspondent email authorized:Yes
Trademark staff tm attorney:PARK, JENNY K
Trademark staff law office assigned RELKYZO:LAW OFFICE 104
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Apr. 18, 2017 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
